Serum cholesterol and coronary heart disease - A public health perspective

Netherlands Journal of Medicine

Volumn 51, Issue 1, 1997, Pages 1-9

  Verschuren, W M M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Coronary heart disease; Epidemiology; HDL cholesterol; Public health; Total cholesterol

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; HEALTH PROGRAM; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MORTALITY; PREVALENCE; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SURVIVAL;

CHOLESTEROL; CHOLESTEROL, HDL; CORONARY DISEASE; DENMARK; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS;

EID: 0030797006     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(97)00019-3     Document Type: Article

References (26)

1. Verschuren WMM. Blood cholesterol - a public health perspective. Thesis, Wageningen, October 1995. ISBN 90-5485-423-5.
2. Verschuren WMM, Smit HA, van Leer EM, et al. Prevalentie van risicofactoren voor hart-en vaatziekten en veranderingen daarin in de periode 1987-1991. Eindrapportage Peilstationsproject Hart-en Vaatziekten 1987-1991. RIVM rapportnr. 528901011, Bilthoven, 1994.
3. Verschuren WMM, Al M, Blokstra A, Boerma GJM, Kromhout D. Trend in serum total cholesterol level in 110,000 young adults in the Netherlands, 1974 to 1986. Am J Epidemiol 1991;134:1290-1302.
4. Verschuren WMM, Boerma GJM, Kromhout D. Total and HDL-cholesterol levels in the Netherlands: 1987-1992. Levels and changes over time in relation to age, gender and educational level. Int J Epidemiol 1994;23:948-956.
5. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscl Thromb 1992;12:911-919.
6. Katan MB. Exit trans fatty acids. Lancet 1995;346:1245-1246.
7. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924.
8. Greenberg ER, Sporn MB. Antioxidant vitamins, cancer and cardiovascular disease. N Engl J Med 1996;334:1189-1190.
9. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease. The Zutphen Elderly Study. Lancet 1993;342:1007-1011.
10. Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). J Am Med Assoc 1986;256:2823-2828.
11. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. J Am Med Assoc 1987;257:2176-2180.
12. Neaton JD, Blackburn H, Jacobs DR, et al. Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial. Arch Intern Med 1992;152: 1490-1500.
13. Verschuren WMM, Kromhout D. Total cholesterol concentration and mortality at a relatively young age: do men and women differ? Br Med J 1995;311:779-783.
14. Verschuren WMM, Jacobs DR, Bloemberg BPM, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five year follow-up of the Seven Countries Study. J Am Med Assoc 1995;274:131-136.
15. de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454-1459.
16. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischemic heart disease? Br Med J 1994;308:367-373.
17. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
18. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-1009.
19. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-1307.
20. Yusuf S, Anand S. Cost of prevention. The case of lipid lowering. Circulation 1996;93:1774-1776.
21. Jacobs DR, Blackburn H, Higgins M, et al. Report of the conference on low blood cholesterol:mortality associations. Circulation 1992;86:1046-1060.
22. Iribarren C, Reed DM, Chen R, Yano K, Dwyer JH. Low serum cholesterol and mortality. Which is the cause and which is the effect? Circulation 1995;92:2396-2403.
23. Brown SL. Lowered serum cholesterol and low mood. The link remains unproved. Br Med J 1996;313:637-638.
24. Truswell AS. Review of dietary intervention studies: effect on coronary events and mortality. Aust NZ J Med 1994;24:98-106.
25. National Cholesterol Education Program (NCEP). Second report of the expert panel on: Detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994;89:1329-1445.
26. Ververs MTC, Verschuren WMM, Boerma GJM, Kromhout D. Het belang van de bepaling van het HDL-cholesterolgehalte voor het classificeren van personen met een vergroot risico van coronaire hartziekten. Ned Tijdschr Geneeskd 1992;136:1023-1027.